US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CITIUS ONCOLOGY INC

1.34

-0.0500-3.60%

Volume:552.82K

Turnover:726.04K

Market Cap:113.63M

PE:-3.58

High:1.41

Open:1.39

Low:1.25

Close:1.39

52wk High:6.19

52wk Low:0.5506

Shares:84.80M

Float Shares:12.32M

Volume Ratio:0.69

T/O Rate:4.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3738

EPS(LYR):-0.3108

ROE:-107.54%

ROA:-22.47%

PB:3.51

PE(LYR):-4.31

Loading ...

Overview Company News Filings

Citius Oncology Signs Exclusive Commercialization Agreement With Eversana to Support Planned Q4 2025 Launch of Lymphir™

THOMSON REUTERS

Citius Sets Up Access to Lymphir in Southern Europe

MT Newswires Live

BRIEF-Citius Oncology Enters Exclusive Distribution Agreement With Integris Pharma S.A.

Citius Oncology Inc - Enters Exclusive Distribution Agreement With Integris Pharma S.a.

THOMSON REUTERS

Citius Oncology Raised to Buy From Hold by Maxim Group

Citius Oncology upgraded to Buy from Hold at Maxim

Citius Oncology Inc : Maxim Group Raises to Buy From Hold

THOMSON REUTERS

BRIEF-Citius Oncology Announces Closing Of $9 Million Registered Direct Offering And Concurrent Private Placement

Citius Oncology Prices $9 Million Securities Offering, Concurrent Private Placement

MT Newswires Live

BRIEF-Citius Oncology Prices $9M Direct Offering & Private Placement

Citius Oncology Inc - Offering Price for Share and Warrant Is $1.75

THOMSON REUTERS

Press Release: Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement

Citius Oncology Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing

THOMSON REUTERS

Citius Oncology Q3 EPS $(0.08) Beats $(0.15) Estimate

Citius Oncology Inc: Qtrly Net Loss $5.4 Mln, or -$0.08 per Share

THOMSON REUTERS

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS

Citius Oncology Inc - Lymphir to Be Commercially Available in Q4 2025

THOMSON REUTERS

Citius Oncology Closes $9 Million Offering of Shares, Warrants

MT Newswires Live

Citius Oncology Prices Public Offering at $1.32 a Share

MT Newswires Live

Citius Oncology Expands Lymphir Distribution With Cencora

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CTOR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CTOR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTOR\",,,,,undefined,":{"symbol":"CTOR","market":"US","secType":"STK","nameCN":"CITIUS ONCOLOGY INC","latestPrice":1.34,"timestamp":1766430456721,"preClose":1.39,"halted":0,"volume":552818,"delay":0,"floatShares":12321000,"shares":84797846,"eps":-0.373844,"marketStatus":"Trading","change":-0.05,"latestTime":"12-22 14:08:15 EST","open":1.39,"high":1.405,"low":1.25,"amount":726041.6407188,"amplitude":0.111511,"askPrice":1.35,"askSize":3000,"bidPrice":1.34,"bidSize":1300,"shortable":0,"etf":0,"ttmEps":-0.373844,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766437200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.39,"preHourTrading":{"tag":"盘前","latestPrice":1.4,"preClose":1.39,"latestTime":"09:29 EST","volume":32117,"amount":44812.3811918,"timestamp":1766413799042},"postHourTrading":{"tag":"盘后","latestPrice":1.3,"preClose":1.39,"latestTime":"19:59 EST","volume":27577,"amount":37242.9177,"timestamp":1766192361348},"volumeRatio":0.691455},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTOR\",,,,,undefined,":{"symbol":"CTOR","floatShares":12321000,"roa":"-22.47%","roe":"-107.54%","lyrEps":-0.310765,"volumeRatio":0.691455,"shares":84797846,"dividePrice":0,"high":1.405,"amplitude":0.111511,"preClose":1.39,"low":1.25,"week52Low":0.5506,"pbRate":"3.51","week52High":6.19,"institutionHeld":0,"latestPrice":1.34,"committee":-0.395349,"eps":-0.373844,"divideRate":0,"volume":552818,"delay":0,"ttmEps":-0.373844,"open":1.39,"prevYearClose":1.15,"prevWeekClose":1.39,"prevMonthClose":1.37,"prevQuarterClose":2.03,"fiveDayClose":1.05,"twentyDayClose":1.13,"sixtyDayClose":2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTOR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"CTOR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTOR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTOR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1758603600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTOR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTOR","date":"2025-12-19","current":-3.437263,"percent":0.719403,"low":-14.569058,"twenty":-5.84457,"median":-4.262949,"eighty":-3.19281,"high":-1.770477,"avg":-4.603687,"sd":1.98212,"marketCap":95205323},"quantilePoints":[{"date":"2024-08-23","current":-7.506449,"twenty":-8.175502,"median":-7.996,"eighty":-7.800179,"marketCap":131199450},{"date":"2024-08-30","current":-6.464428,"twenty":-8.028637,"median":-7.567643,"eighty":-6.639734,"marketCap":126208166},{"date":"2024-09-06","current":-6.847911,"twenty":-7.922567,"median":-7.149219,"eighty":-6.405992,"marketCap":133695091},{"date":"2024-09-13","current":-5.989639,"twenty":-7.726747,"median":-6.50095,"eighty":-6.274513,"marketCap":116938640},{"date":"2024-09-20","current":-6.099206,"twenty":-7.555404,"median":-6.464428,"eighty":-5.97503,"marketCap":119077761},{"date":"2024-09-27","current":-5.222673,"twenty":-7.472896,"median":-6.354861,"eighty":-5.953117,"marketCap":101964790},{"date":"2024-10-04","current":-4.309619,"twenty":-7.088957,"median":-6.190511,"eighty":-5.617113,"marketCap":84138777},{"date":"2024-10-11","current":-3.542653,"twenty":-6.749301,"median":-6.099206,"eighty":-5.018149,"marketCap":69164927},{"date":"2024-10-18","current":-3.944397,"twenty":-6.661648,"median":-5.953117,"eighty":-4.16353,"marketCap":77008372},{"date":"2024-10-25","current":-4.399098,"twenty":-6.559386,"median":-5.916595,"eighty":-4.331532,"marketCap":85885727},{"date":"2024-10-31","current":-4.419185,"twenty":-6.486341,"median":-5.66094,"eighty":-4.324228,"marketCap":86277899},{"date":"2024-11-08","current":-4.602892,"twenty":-6.464428,"median":-5.16789,"eighty":-4.287705,"marketCap":89864492},{"date":"2024-11-15","current":-3.904222,"twenty":-6.464428,"median":-4.930496,"eighty":-4.287705,"marketCap":76224028},{"date":"2024-11-22","current":-3.564201,"twenty":-6.420601,"median":-4.784407,"eighty":-3.944397,"marketCap":69585621},{"date":"2024-11-29","current":-3.356755,"twenty":-6.347557,"median":-4.693102,"eighty":-3.842134,"marketCap":65535551},{"date":"2024-12-06","current":-5.916595,"twenty":-6.296426,"median":-4.747885,"eighty":-3.776395,"marketCap":115512559},{"date":"2024-12-13","current":-3.907874,"twenty":-6.201468,"median":-4.620605,"eighty":-3.842134,"marketCap":76295332},{"date":"2024-12-20","current":-3.871352,"twenty":-6.164946,"median":-4.528752,"eighty":-3.842134,"marketCap":75582291},{"date":"2024-12-27","current":-3.50613,"twenty":-6.135728,"median":-4.435255,"eighty":-3.725263,"marketCap":68451887},{"date":"2025-01-03","current":-4.012144,"twenty":-6.10651,"median":-4.399098,"eighty":-3.717959,"marketCap":84851818},{"date":"2025-01-10","current":-3.992285,"twenty":-6.033466,"median":-4.399098,"eighty":-3.747177,"marketCap":84431834},{"date":"2025-01-17","current":-4.465946,"twenty":-5.967726,"median":-4.376046,"eighty":-3.723807,"marketCap":94449170},{"date":"2025-01-24","current":-4.296782,"twenty":-5.953117,"median":-4.35308,"eighty":-3.739872,"marketCap":90871550},{"date":"2025-01-31","current":-4.262949,"twenty":-5.953117,"median":-4.346141,"eighty":-3.761786,"marketCap":90156026},{"date":"2025-02-07","current":-4.026118,"twenty":-5.938508,"median":-4.309619,"eighty":-3.767526,"marketCap":85147358},{"date":"2025-02-14","current":-4.330615,"twenty":-5.916595,"median":-4.296782,"eighty":-3.799613,"marketCap":91587074},{"date":"2025-02-21","current":-3.72014,"twenty":-5.901986,"median":-4.296782,"eighty":-3.761786,"marketCap":85862882},{"date":"2025-02-28","current":-3.689139,"twenty":-5.807029,"median":-4.262949,"eighty":-3.720436,"marketCap":85147358},{"date":"2025-03-07","current":-3.162119,"twenty":-5.639027,"median":-4.229116,"eighty":-3.689139,"marketCap":72983450},{"date":"2025-03-14","current":-2.294087,"twenty":-5.507546,"median":-4.152992,"eighty":-3.653403,"marketCap":52948777},{"date":"2025-03-21","current":-1.891071,"twenty":-5.317631,"median":-4.127617,"eighty":-3.617985,"marketCap":43646965},{"date":"2025-03-28","current":-2.030577,"twenty":-5.251891,"median":-4.059951,"eighty":-3.565808,"marketCap":46866823},{"date":"2025-04-04","current":-2.191783,"twenty":-5.220193,"median":-4.053963,"eighty":-3.506186,"marketCap":50587548},{"date":"2025-04-11","current":-1.919282,"twenty":-5.198143,"median":-4.02178,"eighty":-3.38992,"marketCap":44298092},{"date":"2025-04-17","current":-2.002676,"twenty":-5.149629,"median":-4.014793,"eighty":-3.224122,"marketCap":46222851},{"date":"2025-04-25","current":-1.987175,"twenty":-5.113107,"median":-3.992285,"eighty":-3.104751,"marketCap":45865089},{"date":"2025-05-02","current":-2.759104,"twenty":-5.076585,"median":-3.944397,"eighty":-2.759104,"marketCap":63681637},{"date":"2025-05-09","current":-2.619599,"twenty":-4.930496,"median":-3.907874,"eighty":-2.693382,"marketCap":60461779},{"date":"2025-05-16","current":-2.437632,"twenty":-4.930496,"median":-3.890787,"eighty":-2.691522,"marketCap":63331031},{"date":"2025-05-23","current":-2.506208,"twenty":-4.784407,"median":-3.875146,"eighty":-2.619599,"marketCap":65112685},{"date":"2025-05-30","current":-2.451953,"twenty":-4.784407,"median":-3.871352,"eighty":-2.502848,"marketCap":63703103},{"date":"2025-06-06","current":-2.671453,"twenty":-4.755189,"median":-3.805483,"eighty":-2.487546,"marketCap":69405829},{"date":"2025-06-13","current":-4.04849,"twenty":-4.660231,"median":-3.776135,"eighty":-2.502848,"marketCap":105182030},{"date":"2025-06-20","current":-4.268817,"twenty":-4.617062,"median":-3.83483,"eighty":-2.506208,"marketCap":110906223},{"date":"2025-06-27","current":-9.639263,"twenty":-4.842843,"median":-3.873249,"eighty":-2.506208,"marketCap":250433407},{"date":"2025-07-03","current":-14.569058,"twenty":-5.098498,"median":-3.876214,"eighty":-2.511716,"marketCap":378512206},{"date":"2025-07-11","current":-8.950744,"twenty":-5.244587,"median":-3.890787,"eighty":-2.545647,"marketCap":232545306},{"date":"2025-07-18","current":-4.40652,"twenty":-5.303022,"median":-3.909331,"eighty":-2.598329,"marketCap":114483843},{"date":"2025-07-25","current":-5.370447,"twenty":-5.303022,"median":-3.944397,"eighty":-2.622079,"marketCap":139527183},{"date":"2025-08-01","current":-7.246465,"twenty":-5.617113,"median":-3.968341,"eighty":-2.631999,"marketCap":188267172},{"date":"2025-08-08","current":-6.066045,"twenty":-5.92757,"median":-3.993409,"eighty":-2.65122,"marketCap":157599217},{"date":"2025-08-15","current":-5.071831,"twenty":-5.92757,"median":-4.017441,"eighty":-2.668242,"marketCap":134797404},{"date":"2025-08-22","current":-4.806444,"twenty":-5.916595,"median":-4.026118,"eighty":-2.679481,"marketCap":127744051},{"date":"2025-08-29","current":-6.251327,"twenty":-5.92757,"median":-4.051227,"eighty":-2.692266,"marketCap":166145638},{"date":"2025-09-05","current":-5.514142,"twenty":-5.933303,"median":-4.056957,"eighty":-2.700326,"marketCap":146552992},{"date":"2025-09-12","current":-5.938837,"twenty":-5.933303,"median":-4.063335,"eighty":-2.734303,"marketCap":157840405},{"date":"2025-09-19","current":-5.498923,"twenty":-5.933303,"median":-4.134553,"eighty":-2.759104,"marketCap":146148523},{"date":"2025-09-26","current":-5.71888,"twenty":-5.924891,"median":-4.16145,"eighty":-2.75929,"marketCap":151994464},{"date":"2025-10-03","current":-5.907415,"twenty":-5.938047,"median":-4.221426,"eighty":-2.76177,"marketCap":157005270},{"date":"2025-10-10","current":-5.750303,"twenty":-5.938047,"median":-4.262949,"eighty":-2.769272,"marketCap":152829598},{"date":"2025-10-17","current":-5.624613,"twenty":-5.934887,"median":-4.265883,"eighty":-2.785269,"marketCap":149489061},{"date":"2025-10-24","current":-5.247544,"twenty":-5.933303,"median":-4.296782,"eighty":-2.845783,"marketCap":139467448},{"date":"2025-10-31","current":-5.436079,"twenty":-5.924891,"median":-4.3032,"eighty":-2.870708,"marketCap":144478254},{"date":"2025-11-07","current":-4.524828,"twenty":-5.916595,"median":-4.309619,"eighty":-2.884898,"marketCap":120259356},{"date":"2025-11-14","current":-4.179182,"twenty":-5.914759,"median":-4.309619,"eighty":-2.896465,"marketCap":111072877},{"date":"2025-11-21","current":-3.550733,"twenty":-5.907415,"median":-4.304871,"eighty":-2.952238,"marketCap":94370189},{"date":"2025-11-28","current":-4.304871,"twenty":-5.907415,"median":-4.296782,"eighty":-3.104751,"marketCap":114413415},{"date":"2025-12-05","current":-3.487889,"twenty":-5.875992,"median":-4.296782,"eighty":-3.112056,"marketCap":92699920},{"date":"2025-12-12","current":-3.550733,"twenty":-5.86799,"median":-4.273096,"eighty":-3.162119,"marketCap":94370189},{"date":"2025-12-19","current":-3.582156,"twenty":-5.84457,"median":-4.262949,"eighty":-3.19281,"marketCap":95205323}],"updateTime":1766421719658},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTOR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575074950","title":"Citius Oncology Signs Exclusive Commercialization Agreement With Eversana to Support Planned Q4 2025 Launch of Lymphir™","url":"https://stock-news.laohu8.com/highlight/detail?id=2575074950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575074950?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:47","pubTimestamp":1760618828,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nTUA1XFCBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","CTXR","CTOR"],"gpt_icon":0},{"id":"2573966243","title":"Citius Sets Up Access to Lymphir in Southern Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2573966243","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573966243?lang=en_us&edition=fundamental","pubTime":"2025-10-07 23:04","pubTimestamp":1759849454,"startTime":"0","endTime":"0","summary":"Citius Oncology  said Tuesday it has entered into an exclusive distribution agreement with Greece-based Integris Pharma to make Lymphir available in Southern Europe.The partnership coverage includes Greece, Cyprus, Malta, Bulgaria, and Romania, it said. Lymphir is a targeted immune therapy for relapsed or refractory cutaneous T-cell lymphoma.The deal is part of its Named Patient Programs, also known as early access programs, Citius said, adding that it is in discussions with distribution partners to make the drug available through the program in Europe, South America and the Middle East.Price: 1.90, Change: +0.03, Percent Change: +1.66","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2384288077.EUR","CTOR","BK4585","LU0310799852.SGD","LU1267930490.SGD","LU1929549753.HKD","LU1621768206.USD","BK4139","LU2133065610.SGD","LU0098860793.USD","LU0211327993.USD","IE00BMG7P694.USD","IE00BMG7P926.USD","LU2347655156.SGD","LU1162221912.USD","IE00B29SXK94.USD","BK4588","LU0211328371.USD","LU0726765562.USD","LU0795875086.SGD","LU0795875169.SGD","IE00BMG7P819.SGD","IE00BMG7P587.USD","LU1621767810.EUR","LU1621768115.EUR","LU0070217475.USD","LU0912757837.SGD","BK4081","LU0320765646.SGD","LU1732799900.SGD","LU1732800096.USD","IE00B29SXL02.USD","SO","LU1718418525.SGD","LU1621767737.EUR","LU2347655073.USD"],"gpt_icon":0},{"id":"2573192950","title":"BRIEF-Citius Oncology Enters Exclusive Distribution Agreement With Integris Pharma S.A.","url":"https://stock-news.laohu8.com/highlight/detail?id=2573192950","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573192950?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:52","pubTimestamp":1759841555,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Enters Exclusive Distribution Agreement With Integris Pharma S.A.Oct 7 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY INC - ENTERS EXCLUSIVE DISTRIBUTION AGREEMENT WITH I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO026:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2573295098","title":"Citius Oncology Inc - Enters Exclusive Distribution Agreement With Integris Pharma S.a.","url":"https://stock-news.laohu8.com/highlight/detail?id=2573295098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573295098?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:48","pubTimestamp":1759841334,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO026:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2569654797","title":"Citius Oncology Raised to Buy From Hold by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2569654797","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569654797?lang=en_us&edition=fundamental","pubTime":"2025-09-23 19:57","pubTimestamp":1758628620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTOR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 23, 2025 07:57 ET (11:57 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2569920427","title":"Citius Oncology  upgraded to Buy from Hold at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2569920427","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569920427?lang=en_us&edition=fundamental","pubTime":"2025-09-23 19:30","pubTimestamp":1758627017,"startTime":"0","endTime":"0","summary":"Maxim analyst Michael Okunewitch upgraded Citius Oncology (CTOR) to Buy from Hold with a $6 price target Published first on TheFly – the ultimate s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citius-oncology-upgraded-to-buy-from-hold-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citius-oncology-upgraded-to-buy-from-hold-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2569792629","title":"Citius Oncology Inc : Maxim Group Raises to Buy From Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2569792629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569792629?lang=en_us&edition=fundamental","pubTime":"2025-09-23 19:27","pubTimestamp":1758626874,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nFWN3VA0KH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2566982490","title":"BRIEF-Citius Oncology Announces Closing Of $9 Million Registered Direct Offering And Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566982490","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566982490?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:34","pubTimestamp":1757536476,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Announces Closing Of $9 Million Registered Direct Offering And Concurrent Private PlacementSept 10 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY ANNOUNCES CLOSING OF $9.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUABKV5FY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","BK4139","BK4007","CTXR"],"gpt_icon":0},{"id":"2566738690","title":"Citius Oncology Prices $9 Million Securities Offering, Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566738690","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566738690?lang=en_us&edition=fundamental","pubTime":"2025-09-09 21:14","pubTimestamp":1757423669,"startTime":"0","endTime":"0","summary":"Citius Oncology  said Tuesday it expects to raise $9 million in gross proceeds from a registered direct offering and concurrent private placement.The company said it has signed an agreement to sell about 5.1 million common shares to an institutional investor at $1.75 apiece.Citius Oncology has also agreed to issue warrants to buy up to roughly 5.1 million common shares, it said, adding that the warrants can be exercised at $1.84 per share.The offering will likely be completed around Wednesday, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2566697542","title":"BRIEF-Citius Oncology Prices $9M Direct Offering & Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566697542","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566697542?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:37","pubTimestamp":1757421421,"startTime":"0","endTime":"0","summary":"BRIEF-Citius Oncology Prices $9M Direct Offering & Private PlacementSept 9 (Reuters) - Citius Oncology Inc CTOR.O:CITIUS ONCOLOGY ANNOUNCES PRICING OF $9.0 MILLION REGISTERED DIRECT OFFERING AND CONCU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA5NXBFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CTXR","CTOR","BK4007"],"gpt_icon":0},{"id":"2566802697","title":"Citius Oncology Inc - Offering Price for Share and Warrant Is $1.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2566802697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566802697?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:30","pubTimestamp":1757421004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUA5NXBFP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CTXR","CTOR","BK4007"],"gpt_icon":0},{"id":"2566697392","title":"Press Release: Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566697392","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566697392?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:30","pubTimestamp":1757421000,"startTime":"0","endTime":"0","summary":"CRANFORD, N.J., Sept. 9, 2025 /PRNewswire/ -- Citius Oncology, Inc.  , the oncology-focused subsidiary of Citius Pharmaceuticals, Inc.  , a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,142,858 shares of common stock in a registered direct offering. In a concurrent private placement, the Company also agreed to issue unregistered warrants to purchase up to an aggregate of 5,142,858 shares of common stock. The combined effective offering price for each share of common stock and accompanying warrant is $1.75. The warrants will have an exercise price of $1.84 per share, will be exercisable six months from the date of issuance, and will expire on the five and one-half year anniversary from the date of issuance.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTXR","R","NQmain","BK4022","CTOR","BK4232","BK4139"],"gpt_icon":0},{"id":"2564165804","title":"Citius Oncology Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2564165804","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564165804?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:01","pubTimestamp":1756814493,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nFWN3UP0EZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2559621794","title":"Citius Oncology Q3 EPS $(0.08) Beats $(0.15) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559621794","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559621794?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:34","pubTimestamp":1755030897,"startTime":"0","endTime":"0","summary":"Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.15) by 46.67 percent. This is a 14.29 percent decrease over losses of $(0.07) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47075303/citius-oncology-q3-eps-0-08-beats-0-15-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Citius Oncology Q3 EPS $(0.08) Beats $(0.15) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR"],"gpt_icon":0},{"id":"2559787621","title":"Citius Oncology Inc: Qtrly Net Loss $5.4 Mln, or -$0.08 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2559787621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559787621?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:30","pubTimestamp":1755030606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nTUA8VL0PZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2559621421","title":"Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2559621421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559621421?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:30","pubTimestamp":1755030606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nTUA8VL0PZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2559212286","title":"Citius Oncology Inc - Lymphir to Be Commercially Available in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559212286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559212286?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:30","pubTimestamp":1755030606,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nTUA8VL0PZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTOR","BK4139"],"gpt_icon":0},{"id":"2552349594","title":"Citius Oncology Closes $9 Million Offering of Shares, Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2552349594","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552349594?lang=en_us&edition=fundamental","pubTime":"2025-07-18 05:11","pubTimestamp":1752786667,"startTime":"0","endTime":"0","summary":"Citius Oncology  closed a $9 million public offering of shares and warrants.The company sold almost 6.82 million shares and related warrants at $1.32 apiece.Proceeds will support Lymphir commercialization, including license payments, and be used for working capital and general corporate purposes, the company said Thursday in a statement.Citius Oncology is a majority-owned subsidiary of Citius Pharmaceuticals .","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTOR","BK4139","CTXR","BK4007"],"gpt_icon":0},{"id":"2551312514","title":"Citius Oncology Prices Public Offering at $1.32 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2551312514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551312514?lang=en_us&edition=fundamental","pubTime":"2025-07-16 21:45","pubTimestamp":1752673532,"startTime":"0","endTime":"0","summary":"Citius Oncology  said Wednesday that it priced its \"reasonable best-efforts\" public offering of about 6.8 million common shares and warrants to purchase common shares at $1.32 per share, for total proceeds of about $9 million.The company said the warrants are immediately exercisable for $1.32 per share and will expire five years from issuance.Citius said net proceeds will be used to support the commercialization of Lymphir and for general corporate purposes. The offering is expected to close on or about Thursday, the company said.Shares of Citius Oncology were down more than 7% in early Wednesday trading.Price: 1.42, Change: -0.12, Percent Change: -7.79","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CTOR"],"gpt_icon":0},{"id":"2551016742","title":"Citius Oncology Expands Lymphir Distribution With Cencora","url":"https://stock-news.laohu8.com/highlight/detail?id=2551016742","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551016742?lang=en_us&edition=fundamental","pubTime":"2025-07-15 21:05","pubTimestamp":1752584750,"startTime":"0","endTime":"0","summary":"Citius Pharmaceuticals'  unit Citius Oncology  said Tuesday it signed a distribution agreement with Cencora to expand a commercial distribution network for Lymphir, a treatment for relapsed or refractory cutaneous T-cell lymphoma.Under the agreement, Cencora will operate as a wholesale distributor for the treatment, enhancing access and availability of Lymphir across treatment centers in the US, the company said.Financial terms of the deal were not disclosed.CTXR and CTOR shares were up 6.6% and 1.5%, respectively, in recent premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CTXR","CTOR","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}]}}